The ISS Program is open to all private practices, hospitals, community health centers,
cooperative groups, physician networks, academic medical centers, and universities who
are interested in conducting their own research.
An Investigator Sponsored Study (ISS) is one for which the Investigator assumes responsibility
for all aspects of the investigation, including:
- Trial design
- Ensuring appropriate institutional and regulatory approval
- Study conduct, including responsibility for ensuring appropriate medical safeguards,
medical monitoring, and medical supervision
- Analysis and interpretation of the results
- Communication of the results (e.g., publications)
Click here to learn more about becoming a sponsor-investigator.
Teams of medical and scientific staff meet regularly to review investigator sponsored
study proposals. Support for these programs is awarded based on scientific merit, patient
safety, unmet medical need, availability of funds, and feasibility of the proposal. Teva
Pharmaceuticals may provide support for these programs in the form of funding and/or
study materials. Funding is dependent upon various factors, including:
- Availability of funds
- Merit of the proposal
- Duration of the proposed study
- Fair Market Value
All protocols and study activities must comply with, and be conducted pursuant to, Good Clinical Practice (GCP) guidelines and applicable statutes and regulations.
The sponsor-investigator must be qualified and capable of conducting the proposed study
in compliance with GCP, applicable federal and local legal requirements, and must not be
the subject of any legal restrictions or sanctions.